Barings Portfolio holdings
Barings is a subsidiary of the insurer MassMutual that invests in fixed income, stocks, real estate and alternative assets. Its core began as David L. Babson & Company, founded in 1940 and bought by MassMutual in 1995. Baring Asset Management, which traces back to a merchant bank the Baring brothers founded in London in 1762, was bought by MassMutual in 2004 and became a Babson subsidiary in 2016. Babson, by then Babson Capital Management, took the Barings name in September 2016, and MassMutual's real estate adviser merged into the firm that December. Its clients include pension plans, endowments, foundations, banks and insurance companies, as well as MassMutual itself.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AEUA
Anadarko Petroleum Corporation
AEUA
|
+$18.2M |
| 2 |
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
|
+$15M |
| 3 |
Gilead Sciences
GILD
|
+$10.2M |
| 4 |
Home Depot
HD
|
+$9.33M |
| 5 |
Merck
MRK
|
+$9.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$11M |
| 2 |
Johnson & Johnson
JNJ
|
+$8.24M |
| 3 |
Union Pacific
UNP
|
+$6.72M |
| 4 |
Metallus
MTUS
|
+$6.41M |
| 5 |
XLS
EXELIS INC COM STK
XLS
|
+$6.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.23% |
| 2 | Technology | 9.28% |
| 3 | Healthcare | 9.19% |
| 4 | Financials | 9.19% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.3B
| $311M | 9.39% |
8,369,200
+592,400
| +8% | +$24.8M |
2013 Q4
6 quarters
|
|
2
PUT
iShares MSCI EAFE ETF
EFA
$77.4B
| $144M | 4.36% |
2,225,000
+165,000
| +8% | +$11M |
2013 Q4
6 quarters
|
|
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
| $129M | 3.91% |
6,023,400
-170,000
| -3% | -$35.7M |
2013 Q4
6 quarters
|
|
4
Apple
AAPL
$5.17T
| $69.4M | 2.1% |
2,213,264
+272,560
| +14% | +$8.72M |
2013 Q2
8 quarters
|
|
5
iShares Russell 3000 ETF
IWV
$20.4B
| $62.3M | 1.88% |
502,589
-12,900
| -3% | -$1.62M |
2013 Q2
8 quarters
|
|
6
PUT
iShares Russell 2000 ETF
IWM
$78B
| $46.7M | 1.41% |
380,000
-310,000
| -45% | -$38.7M |
2014 Q3
3 quarters
|
|
7
Microsoft
MSFT
$3.92T
| $37.6M | 1.14% |
852,596
+176,700
| +26% | +$8.06M |
2013 Q2
8 quarters
|
|
8
ExxonMobil
XOM
$694B
| $24.8M | 0.75% |
298,446
+6,300
| +2% | +$542K |
2013 Q2
8 quarters
|
|
9
BlackRock TCP Capital
TCPC
$346M
| $24.5M | 0.74% |
1,603,372
| – | – |
2013 Q2
8 quarters
|
|
|
10
Gilead Sciences
GILD
$211B
| $23.7M | 0.72% |
202,642
+93,730
| +86% | +$10.2M |
2013 Q2
8 quarters
|
|
11
Citigroup
C
$206B
| $22.9M | 0.69% |
415,232
+94,800
| +30% | +$5.16M |
2013 Q2
8 quarters
|
|
12
Berkshire Hathaway Class B
BRK.B
$1.26T
| $21.7M | 0.66% |
159,749
+9,850
| +7% | +$1.4M |
2013 Q2
8 quarters
|
|
|
13
Johnson & Johnson
JNJ
$686B
| $21.3M | 0.64% |
218,070
-82,280
| -27% | -$8.24M |
2013 Q2
8 quarters
|
|
14
JPMorgan Chase
JPM
$914B
| $21.1M | 0.64% |
312,043
+55,800
| +22% | +$3.64M |
2013 Q2
8 quarters
|
|
15
GE Aerospace
GE
$350B
| $20.3M | 0.61% |
159,606
-34,012
| -18% | -$4.41M |
2013 Q2
8 quarters
|
|
16
Wells Fargo
WFC
$258B
| $19.5M | 0.59% |
346,980
+60,000
| +21% | +$3.35M |
2013 Q2
8 quarters
|
|
17
Verizon
VZ
$194B
| $19.1M | 0.58% |
409,587
+98,800
| +32% | +$4.84M |
2013 Q2
8 quarters
|
|
|
AEUA
18
DELISTED
Anadarko Petroleum Corporation
AEUA
| $18.1M | 0.55% |
+360,000
| New | +$18.2M |
2015 Q2
0 quarters
|
|
19
Walt Disney
DIS
$205B
| $18.1M | 0.55% |
158,604
+37,893
| +31% | +$4.16M |
2013 Q2
8 quarters
|
|
|
20
Home Depot
HD
$349B
| $17.9M | 0.54% |
161,127
+83,330
| +107% | +$9.33M |
2013 Q2
8 quarters
|
|
|
21
Merck
MRK
$366B
| $17.8M | 0.54% |
327,063
+164,536
| +101% | +$9.23M |
2013 Q2
8 quarters
|
|
|
SWNC
22
DELISTED
Southwestern Energy Company
SWNC
| $17.4M | 0.53% |
350,000
| – | – |
2015 Q1
1 quarter
|
|
23
Amgen
AMGN
$255B
| $17.1M | 0.52% |
111,676
+1,750
| +2% | +$280K |
2013 Q2
8 quarters
|
|
24
Intel
INTC
$329B
| $15.9M | 0.48% |
521,634
-96,200
| -16% | -$3.11M |
2013 Q2
8 quarters
|
|
25
Pfizer
PFE
$166B
| $15.8M | 0.48% |
495,576
-87,904
| -15% | -$2.86M |
2013 Q2
8 quarters
|
|
Similar funds
Barings's Q2 2015 Portfolio in Review
As of Q2 2015, Barings held 1,106 positions worth $3.31B, down 24% from $4.37B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barings withdrew a net $246M in Q2 2015, closing 134 positions and reducing 276 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $11M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Barings opened a new position in Anadarko Petroleum Corporation worth $18.1M.
- Barings's largest Q2 2015 buy was Anadarko Petroleum Corporation: 360,000 shares worth $18.1M.
- Barings added most to Gilead Sciences in Q2 2015, an estimated $10.2M increase.
- Barings's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $8.24M.
- Barings fully exited iShares Russell 1000 Growth ETF in Q2 2015, selling an estimated $11M.
- Barings's ten largest holdings make up 27% of its $3.31B portfolio in Q2 2015.
- Barings opened 139 new positions and closed 134 in Q2 2015.
- Barings's portfolio value fell 24% quarter-over-quarter to $3.31B.
Based on Barings's 13F filing for Q2 2015, filed 14 Aug 2015.